THE PATENTABILITY OF HUMAN EMBRYONIC STEM CELLS: IS THE CONSISTENT APPLICATION OF THE EUROPEAN UNION BIOTECHNOLOGY DIRECTIVE'S MORAL EXCLUSION CLAUSE UNDERMINING INVESTOR CONFIDENCE IN EUROPE, PROVIDING A COMPETITIVE ADVANTAGE TO THE UNITED STATES?
- Published in:
- Dalhousie Journal of Legal Studies, 2011, v. 20, p. 106
- By:
- Publication type:
- Article